for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Navidea Biopharmaceuticals Reports Q4 Loss Per Share Of $0.15

March 11 (Reuters) - Navidea Biopharmaceuticals Inc :

* NAVIDEA BIOPHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

* Q4 REVENUE $119,000

* Q4 LOSS PER SHARE $0.15 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up